Sophiris Bio Inc.
(NASDAQ : SPHS)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Bitcoin & Crypto Movers
Receive our Bitcoin / Cryptocurrency Reports, Free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
AMGNAmgen Inc.
0.37%183.661.1%$863.33m
GILDGilead Sciences, Inc.
-0.26%80.730.9%$828.11m
CELGCelgene Corporation
1.05%94.841.2%$768.91m
JUNOJuno Therapeutics, Inc.
1.96%86.6513.5%$580.24m
BIIBBiogen Inc.
0.48%288.831.2%$512.39m
REGNRegeneron Pharmaceuticals, Inc.
-1.09%319.522.7%$396.38m
VRTXVertex Pharmaceuticals Incorporated
-1.67%158.301.9%$353.37m
ALXNAlexion Pharmaceuticals, Inc.
-0.44%118.332.0%$255.49m
NKTRNektar Therapeutics
1.35%84.586.0%$250.40m
ILMNIllumina, Inc.
0.01%226.583.5%$230.72m
BLUEBluebird Bio, Inc.
1.95%209.4516.1%$195.69m
AAgilent Technologies, Inc.
1.44%72.101.5%$178.13m
INCYIncyte Corporation
0.47%85.912.5%$154.84m
BMRNBioMarin Pharmaceutical Inc.
1.01%84.704.4%$122.41m
EXASExact Sciences Corporation
-0.32%47.8626.0%$117.80m

Company Profile

Sophiris Bio, Inc. is a clinical-stage biopharmaceutical company, which develops products for the treatment of urological diseases. It is currently developing PRX302 as a treatment for the symptoms of benign prostatic hyperplasia which is a non cancerous enlargement of the prostate gland that causes a restriction in urine flow from the urethra resulting in lower urinary tract symptoms. The company was founded by Jim L. Heppell in May 2003 and is headquartered in La Jolla, CA.